Close

content

Novavax to Supply 76M Doses of COVID-19 Vax to Canada

Novavax, Inc. has reached an agreement in principle with the Government of Canada to supply up to 76 million doses of NVX-CoV2373, Novavax’ COVID-19...

FDA Clears SPI’s Ebselen for Phase II COVID-19 Trials

Sound Pharmaceuticals, Inc. (SPI) received clearance from the FDA to begin two Phase 2 studies of ebselen (SPI-1005) in COVID-19 patients. SPI-1005 is a...

Alcami Providing Commercial Manufacturing for Trevena’s Recently FDA Approved OLINVYK

Alcami, a US-based contract development and manufacturing organization (CDMO), announced that it is providing commercial manufacturing services for Trevena’s newly approved OLINVYK. OLINVYK (oliceridine)...

iBio Signs License Agreement with Planet Biotechnology for COVID-19 Therapeutic

iBio Inc., a biotechnology innovator and biologics contract manufacturing organization, has entered into an exclusive worldwide license agreement with Planet Biotechnology Inc. for the...

Promega Launches Spectrum Compact CE Benchtop DNA Analysis Instrument with Hitachi High-Tech

Promega launched its benchtop capillary electrophoresis (CE) instrument, the Spectrum Compact CE System, developed in collaboration with Hitachi High-Tech. The personal CE system is...

CluePoints Joins Forces with Global Growth Investor Summit Partners to Expand Market Leadership Position in Risk-Based Quality Management

CluePoints S.A., a provider of Risk-Based Study Execution (RBx) and Data Quality Oversight software for clinical trials, announced a minority investment from Summit Partners,...

Uni-Bio Science Group Announces 2020 Interim Results

A fully integrated biopharmaceutical company - Uni-Bio Science Group Limited, is pleased to announce its interim results for six months ended 30 June 2020...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read